23 Jul, 2026
The global data analysis, storage, and management market size reached USD 27,981.98 million in 2025 and is anticipated to grow from USD 31,367.8 million in 2026 to USD 78,222 million by 2034, expanding at a CAGR of 12.1% over the forecast period from 2026 to 2034.
Data storage management includes monitoring software and hardware resources, including storage arrays, physical servers, and cloud storage services. Data storage management may involve resolving performance issues, such as potential bottlenecks, and examining real-time storage capacity in order to improve the end-user experience. Administrators can use this data to reassign storage resources to accommodate business storage requirements.
There will be more data to be analyzed as technology advances. One terabyte of data can be produced every hour by Next-generation Sequencing (NGS) machinery used in the field of genomic research, for example. The vast amounts of data generated can be used to create personalized medicine, boost R&D productivity, and assess the advantages and dangers of clinical trials. It also aids in price control, budget research, and profit forecasting. Wearable, implantable, and remote health monitoring devices send data directly from a patient's location to a hospital or healthcare provider. As the number of implants and wearable devices increases, so is expected to the demand for data analysis and storage in the life sciences. With the widespread adoption of new technologies like telemedicine, virtual clinical trials, and AI, access to medical research may improve, and diversity may rise.
Companies can change processes and gain a competitive edge by fusing medical and scientific knowledge. It can speed up the development of new drugs, design new compounds, increase supply chain responsiveness and intelligence, and launch and market new products. It can locate and approve genetic drug targets. In addition, the top three AI issues are dealing with data problems (28%), integrating AI into the organization (28%), and identifying high-value business cases (30%). Data analytics are anticipated to be used more frequently throughout the biopharma value chain, from molecule to market, due to the explosion in healthcare data and technological developments in cognitive computing and machine learning. Furthermore, GSK (UK), 23&Me (US), Sanofi (France), and Google recently launched initiatives to improve treatment outcomes through a better understanding of patient populations and diseases genetically.
North America is the most significant shareholder in the global data analysis, storage, and management market and is expected to advance at a CAGR of 12.4% during the forecast period. The region holds a 32.0% market share due to North America's rising incidence of chronic illnesses and other cardiovascular disorders and the expansion of big data in the healthcare industry. It is highly desirable for hospital or healthcare staff to spend less time managing data. In addition, the region's abundance of pharmaceutical and biotechnology companies that focus on drug development and generate enormous amounts of data also helps the market grow.
Europe is expected to grow at a CAGR of 11.5% during the forecast period. It is anticipated to experience significant growth during the forecast period due to the highly developed technology, high healthcare spending, presence of key players, and rising adoption of big data analysis and cloud-based solutions. Additionally, a deal to create a Public-Private Partnership (PPP) in the data industry was signed in 2014 by the European Union and the Big Data Value Association (BDVA). One of the PPP-funded projects is BigMedilytics, which aims to use big data to transform the healthcare sector. The project comprises 12 pilots and addresses every aspect of healthcare, from home care to diagnosis and treatment to prevention. Population health and chronic disease management, oncology, and the industrialization of healthcare services are the three topics that affect the sector the most. Therefore, the factors above are anticipated to favor the development of the global data analysis, storage, and management market for the life sciences in Europe during the study period.
sales@straitsresearch.com